SaxoCell
Private Company
Total funding raised: $2.8M
Overview
SaxoCell is a privately held, non-profit consortium founded in 2001 and based in Dresden, Germany. It operates as a regional innovation cluster uniting academic, clinical, and industrial partners to advance the field of cell and gene therapy. Its core mission is to develop more affordable and accessible allogeneic (off-the-shelf) cell therapeutics through research projects focused on novel applications, production methods, and automation. The cluster is pre-revenue, acting as a collaborative R&D and technology transfer engine rather than a single commercial biotech entity.
Technology Platform
Focus on developing allogeneic (off-the-shelf) cell therapeutics and automated, scalable manufacturing processes to reduce costs and increase accessibility of cell and gene therapies.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
SaxoCell competes with other regional life science clusters and academic consortia globally, such as those in Cambridge (UK), Boston (USA), and Basel (Switzerland). Its differentiation lies in its specific focus on allogeneic therapy manufacturing and its integrated network within the strong German research ecosystem.